Company profile: Shockwave Medical
1.1 - Company Overview
Company description
- Provider of intravascular lithotripsy (IVL) solutions for treating calcified coronary and peripheral arteries, including balloon dilatation catheters with lithotripsy electrodes that increase lesion compliance prior to low‑pressure dilation to limit injury to healthy tissue. Offerings include Shockwave C2+, L6, M5+, S4 IVL catheters, the IVL Generator, and the Shockwave Reducer System for refractory angina pectoris.
Products and services
- Shockwave C2+: Engineered catheter-based coronary IVL device incorporating tiny lithotripsy electrodes delivering calcium-cracking pulses to increase compliance of rigid lesions before low-pressure dilation, minimizing injury to healthy tissue
- Shockwave M5+: Versatile endovascular IVL catheter for above- and below-the-knee treatments, architected with tiny lithotripsy electrodes and faster cycle time to prepare calcified lesions for low-pressure dilation while limiting injury
- IVL Generator: Portable IVL generator powering catheters via simple magnetic connections and push-button activation, engineered for streamlined delivery of calcium-cracking pulses during revascularization procedures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Shockwave Medical
WR Medical
HQ: United States
Website
- Description: Provider of medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WR Medical company profile →
QT Medical
HQ: United States
Website
- Description: Provider of cloud-connected cardiac monitoring devices, including PCA 500, a compact wireless 12-lead ECG with pre-positioned single-use electrodes and HIPAA-compliant cloud data management; single-use electrode strips for quick, accurate lead placement; and Xpress ECG, an online mail-delivery at-home 12-lead ECG service with cloud uploads for remote physician review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QT Medical company profile →
Tarilian Laser Technologies
HQ: United Kingdom
Website
- Description: Provider of medical technology pioneering an innovative breakthrough in blood pressure monitoring through an unobtrusive wrist-worn wearable device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tarilian Laser Technologies company profile →
Longeveron
HQ: United States
Website
- Description: Provider of cellular therapies and research programs, developing Lomecel-B, a culture-expanded medicinal signaling cell (MSC) therapy for aging-related diseases, Alzheimer’s disease, and hypoplastic left heart syndrome (HLHS), with programs testing its use in aging frailty, metabolic syndrome, and acute respiratory distress syndrome (ARDS) due to COVID-19 or influenza.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Longeveron company profile →
Tenaya Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage gene and small molecule therapies for heart diseases, including TN-201 for MYBPC3-associated hypertrophic cardiomyopathy, TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, and TN-301, an HDAC6 inhibitor for heart failure with preserved ejection fraction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tenaya Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Shockwave Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Shockwave Medical
2.2 - Growth funds investing in similar companies to Shockwave Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Shockwave Medical
4.2 - Public trading comparable groups for Shockwave Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →